Phytopharm obesity drug suffers setback

Phytopharm, the company trying to develop drugs from plant extracts, suffered a big setback yesterday when Pfizer - the biggest drug company in the world - abandoned work on its much-hyped treatment for obesity.

The news wiped a third off Phytopharm's market value, although the ebullient chief executive, Richard Dixey, argued the drug would still get to market, and the delay could even improve the company's future profitability.

The drug development project, codenamed P57, is based on a Kalahari desert cactus, known as a Hoodia, which has been used for centuries as an appetite suppressant by the San people in southern Africa.

Pfizer had been preparing to launch a final stage of human trials in the autumn, but has been cutting back work on natural medicines in the wake of its $260bn merger with Pharmacia.

Mr Dixey argued that the stock market reaction - sending the shares down 85p to 175p - was ill-judged. "The drug has been returned to us because of a restructuring within Pfizer, not because it has failed, and any reaction of the share price has to be looked at in that light."

Pfizer signed up in 1988 to work on P57 and had been funding much of the development. Its decision to abandon the project and hand back the rights to the product to Phytopharm robs the UK company of the prospect that the world's biggest drug salesforce will be marketing its drug. More immediately, it means a $2m milestone payment will not come in as expected in the autumn.

Mr Dixey said that "seven of the top 10 multinationals" had previously expressed an interest in P57 and he was confident of finding a new partner. "We are now able to open up the doors and we hope to begin that process very shortly. We hope to have concluded that work by the half-year and if we do so this could actually be cash-positive rather than cash-neutral."

He argued that positive results from the human trials conducted by Pfizer to date should allow Phytopharm to get a better deal from a new licensee than it got from Pfizer in 1988.

Shares in Phytopharm are back only to their levels of three months ago, before a Panorama documentary on the San, featuring Mr Dixey, who is a buddhist, reignited stock market interest. The stock has been an erratic performer, peaking as high as 880p in 2001, but tumbling back after one of the company's most-hyped products, a treatment for baldness, turned out to be less effective than E45 moisturising cream. There was also hilarity when its treatment for arthritis in dogs made their coats smell of urine.

Start your day with The Independent, sign up for daily news emails
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Evening Administrator

£8 per hour: Recruitment Genius: This Pension Specialist was established early...

Guru Careers: Executive Assistant / PA

£30 - 35k + Bonus & Benefits: Guru Careers: We are seeking an Executive Assist...

Ashdown Group: Graduate Application Support Analyst

£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...

Reach Volunteering: External Finance Trustee Needed!

Voluntary post, reasonable expenses reimbursed: Reach Volunteering: Would you ...

Day In a Page

War with Isis: Iraq's government fights to win back Tikrit from militants - but then what?

Baghdad fights to win back Tikrit from Isis – but then what?

Patrick Cockburn reports from Kirkuk on a conflict which sectarianism has made intractable
Living with Alzheimer's: What is it really like to be diagnosed with early-onset dementia?

What is it like to live with Alzheimer's?

Depicting early-onset Alzheimer's, the film 'Still Alice' had a profound effect on Joy Watson, who lives with the illness. She tells Kate Hilpern how she's coped with the diagnosis
The Internet of Things: Meet the British salesman who gave real-world items a virtual life

Setting in motion the Internet of Things

British salesman Kevin Ashton gave real-world items a virtual life
Election 2015: Latest polling reveals Tories and Labour on course to win the same number of seats - with the SNP holding the balance of power

Election 2015: A dead heat between Mr Bean and Dick Dastardly!

Lord Ashcroft reveals latest polling – and which character voters associate with each leader
Audiences queue up for 'true stories told live' as cult competition The Moth goes global

Cult competition The Moth goes global

The non-profit 'slam storytelling' competition was founded in 1997 by the novelist George Dawes Green and has seen Malcolm Gladwell, Salman Rushdie and Molly Ringwald all take their turn at the mic
Pakistani women come out fighting: A hard-hitting play focuses on female Muslim boxers

Pakistani women come out fighting

Hard-hitting new play 'No Guts, No Heart, No Glory' focuses on female Muslim boxers
Leonora Carrington transcended her stolid background to become an avant garde star

Surreal deal: Leonora Carrington

The artist transcended her stolid background to become an avant garde star
LGBT History Month: Pupils discuss topics from Sappho to same-sex marriage

Education: LGBT History Month

Pupils have been discussing topics from Sappho to same-sex marriage
11 best gel eyeliners

Go bold this season: 11 best gel eyeliners

Use an ink pot eyeliner to go bold on the eyes with this season's feline flicked winged liner
Cricket World Cup 2015: Tournament runs riot to make the event more hit than miss...

Cricket World Cup runs riot to make the event more hit than miss...

The tournament has reached its halfway mark and scores of 300 and amazing catches abound. One thing never changes, though – everyone loves beating England
Katarina Johnson-Thompson: Heptathlete ready to jump at first major title

Katarina Johnson-Thompson: Ready to jump at first major title

After her 2014 was ruined by injury, 21-year-old Briton is leading pentathlete going into this week’s European Indoors. Now she intends to turn form into gold
Syrian conflict is the world's first 'climate change war', say scientists, but it won't be the last one

Climate change key in Syrian conflict

And it will trigger more war in future
How I outwitted the Gestapo

How I outwitted the Gestapo

My life as a Jew in wartime Berlin
The nation's favourite animal revealed

The nation's favourite animal revealed

Women like cuddly creatures whilst men like creepy-crawlies
Is this the way to get young people to vote?

Getting young people to vote

From #VOTESELFISH to Bite the Ballot